66.78MMarket Cap-4415P/E (TTM)
4.990High4.650Low6.64KVolume4.760Open4.780Pre Close32.52KTurnover0.10%Turnover RatioLossP/E (Static)13.71MShares11.44052wk High6.87P/B31.35MFloat Cap2.01052wk Low--Dividend TTM6.44MShs Float11.440Historical High--Div YieldTTM7.11%Amplitude2.010Historical Low4.895Avg Price1Lot Size
Intensity Therapeutics Stock Forum
Intensity Therapeutics Signs Collaboration Agreement With The Swiss Group For Clinical Cancer Research SAKK To Conduct Phase 2 Breast Cancer Trial In Europe For INT230-6
NEWS
Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Sign a Collaboration Agreement to Conduct a Phase 2 Randomized, Clinical Trial in Early-Stage Breast Cancer in Europe for INT230-6, Intensity's Lead Drug Candidate
Positive
The collaboration agreement between Intensity Therapeutics, Inc. and SAKK for the Phase 2 clinical trial demonstrates the company's commitment to advancing its lead drug candidate, INT230-6.
INT230-6 has s...
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$...
Benzinga· 3 mins ago
🔥 biotech company focused on interventions for inflammatory and oncologic diseases
🔥 Strong technical setup: 4-hour chart demonstrating bullish descending wedge
🔥 Strong pipeline with recently published positive Phase 1 data for TH104, its lead candidate for chronic pruritus in PBC
🔥 Market cap $1m, highly undervalued, should easily be a minimum $6m market cap
🔥Oversold, RSI 25
🔥 Recently closed offering (priced at $1.00/sh),...
hooo
Crossing fingers for a good holiday rally 🎅 ☃️
$Intensity Therapeutics(INTS.US)$
$African Agriculture(AAGR.US)$
$Cyngn(CYN.US)$
$PaxMedica(PXMD.US)$
$U Power(UCAR.US)$
$WiSA Technologies(WISA.US)$
$SPDR S&P 500 ETF(SPY.US)$